Dental Group: Murphy George DDS ,
-
Aurora Bay Area Prices – HB L3933 FINGER ORTHOSIS WITHOUT JOINTS is $280
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10007057, regarding HB L3933 FINGER ORTHOSIS WITHOUT JOINTS, which is classified under revenue code 274 and associated with CPT code L3933, the designated fee stands at $280. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Bay Area Prices – PH BODY FLUID is $50
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10001061, regarding PH BODY FLUID, which is classified under revenue code 301 and associated with CPT code 83986, the designated fee stands at $50. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Bay Area Prices – MR LOWER EXREM W/O DYE is $4,040.00
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002443, regarding MR LOWER EXREM W/O DYE, which is classified under revenue code 610 and associated with CPT code 73718, the designated fee stands at $4,040.00. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Common Blood Disorders: Anemia, Leukemia, and Hemophilia
In conclusion, understanding common blood disorders like anemia, leukemia, and hemophilia is crucial for early diagnosis and effective treatment. These conditions, though varied in their manifestations and severity, share the common thread of significantly impacting patients’ lives. Anemia, with its widespread prevalence, often requires lifestyle adjustments and medical interventions to manage symptoms and improve quality of life. Leukemia, a more severe and life-threatening condition, necessitates prompt and aggressive treatment strategies, including chemotherapy and bone marrow transplants. Hemophilia, a genetic disorder, demands lifelong management through clotting factor replacement and vigilant monitoring to prevent complications. Healthcare professionals must stay informed about the latest advancements in the diagnosis and treatment of these blood disorders to provide optimal care. Continued research and education are essential in developing more effective therapies and improving patient outcomes. By fostering a comprehensive understanding of these conditions, the medical community can better support those affected and work towards a future where these disorders are more easily managed, if not entirely eradicated.
